Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Predictive genetic testing for hereditary breast cancer and hereditary nonpolyposis colorectal cancer].

Versicherungsmedizin - 1 Sept 2007

Heyll U, Slany E

Abstract excerpt

Genetic tests are no longer used exclusively for diagnostic purposes, but they serve in increasing numbers to assess the predisposition for illnesses. Predictive genetic testing of this kind includes screening for genetic predispositions towards tumours. Of special significance are familial breast and ovarian cancer caused by BRCA1 - and BRCA2- mutations and hereditary nonpolyposis colorectal cancer (HNPCC). The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Colorectal Neoplasms, Hereditary Nonpolyposis
Share to Genetic Counseling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germany

Share to Risk Assessment

Share to Risk Factors

Source

Identifiers

PMID: 17912887

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Predictive genetic testing for hereditary breast cancer and hereditary nonpolyposis colorectal cancer].PMID 17912887Read ↗

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].Semantic proximity Read ↗

[Clinical-genetic care of BRCA-mutation carrier women: prevention, diagnosis and therapy].Semantic proximity Read ↗

[Genes beyond BRCA1 and BRCA2 for hereditary breast cancer].Semantic proximity Read ↗

[DNA-based diagnosis of hereditary tumour predisposition].Semantic proximity Read ↗

[New genetic tests and their clinical utility for cancer screening].Semantic proximity Read ↗

[Who must be referred for genetic counseling?]Semantic proximity Read ↗

[Genetic consultation: hereditary cancer risk?].Semantic proximity Read ↗

[Targeted Early Detection and Prevention of Hereditary Colorectal Carcinomas].Semantic proximity Read ↗

[Hereditary predisposition for the development of breast and ovarian carcinoma].Semantic proximity Read ↗

[Recommended Extension of Indication Criteria for Genetic Testing of BRCA1 and BRCA2 Mutations in Hereditary Breast and Ovarian Cancer Syndrome].Semantic proximity Read ↗

Genetic testing and familial implications in breast-ovarian cancer families.Semantic proximity Read ↗

[Significance of the identification of hereditary cancer for routine oncological diagnosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.